Q1 2016 13F Holders as of 31 Mar 2016
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
192,975,286
-
Total 13F shares
-
162,459,664
-
Share change
-
+1,228,483
-
Total reported value
-
$13,396,780,263
-
Put/Call ratio
-
78%
-
Price per share
-
$82.48
-
Number of holders
-
379
-
Value change
-
+$49,991,390
-
Number of buys
-
203
-
Number of sells
-
170
Institutional Holders of BIOMARIN PHARMACEUTICAL INC - Common Stock (BMRN) as of Q1 2016
As of 31 Mar 2016,
BIOMARIN PHARMACEUTICAL INC - Common Stock (BMRN) was held by
379 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
162,459,664 shares.
The largest 10 holders included
Capital Research Global Investors, FMR LLC, SANDS CAPITAL MANAGEMENT, LLC, VANGUARD GROUP INC, JENNISON ASSOCIATES LLC, PRIMECAP MANAGEMENT CO/CA/, PRICE T ROWE ASSOCIATES INC /MD/, BAKER BROS. ADVISORS LP, JPMORGAN CHASE & CO, and BlackRock Institutional Trust Company, N.A..
This page lists
379
institutional shareholders reporting positions in this security
for the Q1 2016 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.